Federal Funds Retained for 9/11 Health Studies

Officials secured $13 million in research funding for survivors and responders after administrative delays.

Updated on Sept. 30, 2026 in COVID-19

Isometric editorial illustration of a stack of brass-colored storage units, representing institutional research stability.
The federal government has secured $13 million in research funding for 9/11-related health studies, overcoming administrative delays at the Centers for Disease Control and Prevention. AI Illustration. Upload story photo >

Live Poll

Should the federal government guarantee funding for long-term health research on 9/11 survivors?

The federal government has successfully retained $13 million in research funding dedicated to 9/11-related health studies. This outcome follows concerns over administrative delays in grant approvals at the Centers for Disease Control and Prevention that threatened the allocation.

Why it matters

Securing these funds ensures the continuation of long-term medical monitoring and research for survivors and responders. By preventing the loss of these dollars, the program avoids a disruption in the longitudinal data collection necessary for understanding chronic conditions linked to the 2001 attacks.

Official reports confirm that $13 million in mandatory research funding was retained for 9/11 health studies, complementing the $7 million in grants already approved for the fiscal year. It remains unknown which specific studies will receive the pending grant awards by the end of 2026.

The players

Centers for Disease Control and Prevention

The federal public health agency responsible for managing research grants and national disease surveillance.

Department of Health and Human Services

The cabinet-level department tasked with overseeing health policy and reviewing pending medical research grant applications.

The details

The $13 million is part of a mandatory funding pool established by the James Zadroga 9/11 Health and Compensation Act of 2011. Because this is mandatory rather than discretionary, the funds are protected from expiring and can roll over into the next fiscal year. This mechanism provides a buffer against the grant approval delays recently experienced by the Centers for Disease Control and Prevention during a period of widespread staffing changes.

Timeline

  1. September 11, 2001: The terrorist attacks impacting responders and survivors.

  2. 2011: Enactment of the James Zadroga 9/11 Health and Compensation Act.

  3. September 30, 2026: End of the federal fiscal budget year.

  4. End of 2026: Expected award of remaining research grants.

Health Landscape

This development follows the statutory framework established by the James Zadroga 9/11 Health and Compensation Act of 2011. It highlights the continued reliance on mandatory federal funding to sustain longitudinal medical research decades after the initial environmental exposures.

This funding ensures that ongoing health monitoring programs for survivors and responders remain operational and supported. If you are part of a 9/11 health surveillance program, discuss any concerns about access to local clinical services with your primary physician.

The takeaway

The federal government has secured the necessary funding to continue critical long-term health research for those affected by the 2001 attacks. Readers should continue to monitor updates from their established health program coordinators regarding any changes to research participation or local clinic access.

What happens next

The Department of Health and Human Services expects to award the remaining research grants by the end of 2026.

Further reading

For broader context on health policy and chronic disease research, visit the COVID-19 section.

Source note: This article includes information reported by Newsday.

Live Poll

Should the federal government guarantee funding for long-term health research on 9/11 survivors?